It has been demonstrated that ARID1A alterations compromise the mismatch repair system; thus ARID1A defects are associated with MSI and high TMB, which can ultimately affect disease-free survival and overall survival of patients with advanced gastric cancer [45]. The gene discussed is ARID1A; the disease is gastric cancer.